Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Inpharmatics Co-Founder Lee Hartwell Wins Nobel Prize


Lee Hartwell, director of the Fred Hutchinson Cancer Research Center in Seattle and co-developer of a key technology behind the founding of Rosetta Inpharmatics, was among three winners of this year’s Nobel Prize in Physiology or Medicine.

Hartwell, along with Paul Nurse and Timothy Hunt of the Imperial Cancer Research Fund in London, were recognized for their discoveries of molecular mechanisms that regulate the cell cycle.

Hartwell’s work on cell-cycle cancer research under Fred Hutchinson’s Seattle Project led almost directly to his co-founding of Rosetta: Hartwell recruited Stephen Friend from Harvard to work with him on the project and the two developed a method for examining large patterns of genes. Along with Lee Hood, Hartwell and Friend founded Rosetta Inpharmatics in 1996.

Rosetta was acquired by Merck in July.

The Nobel Committee awarded Hartwell for his discoveries of a specific class of genes that control the cell cycle. One of these genes, called start, was found to have a central role in controlling the first step of each cell cycle.

Nurse was recognized for identifying one of the key regulators of the cell cycle, CDK (cyclin dependent kinase), while Hunt was awarded for his discovery of cyclins, proteins that regulate the CDK function.

— BT

Filed under

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.